Stay updated on EoE Efficacy & Safety of APT-1011 Clinical Trial
Sign up to get notified when there's something new on the EoE Efficacy & Safety of APT-1011 Clinical Trial page.

Latest updates to the EoE Efficacy & Safety of APT-1011 Clinical Trial page
- Check5 days agoChange DetectedThe updates on the Study Details page involve minor UI adjustments and small text edits, with no changes to the study design, primary/secondary outcomes, eligibility criteria, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check41 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision updated from v3.0.0 to v3.0.2, indicating a minor metadata/patch update with no substantive content changes.SummaryDifference0.0%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of various medical topics related to digestive and lymphatic diseases. Notably, the page has also seen the removal of previous location details and specific drug information.SummaryDifference3%

- Check84 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%

Stay in the know with updates to EoE Efficacy & Safety of APT-1011 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EoE Efficacy & Safety of APT-1011 Clinical Trial page.